Oxidative Stress and Skin Aging – What Research Knows Today
For decades, free radicals have been considered the main culprits of skin aging. Current science paints a more nuanced, fascinating picture – with implications for skincare.
- How Reactive Oxygen Species (ROS) are Formed in the Skin
- The Antioxidant Enzyme System: SOD, Catalase, and Glutathione Peroxidase
- Exogenous Antioxidants: Vitamin C, E, Resveratrol, Astaxanthin, and More
- Synergies and Interactions in the Antioxidant Network
- Inflammaging: Chronic Inflammation as a Major Driver of Skin Aging
- Latest Research Findings and Their Significance for Skincare
The idea that free radicals cause us to age is not new. Denham Harman formulated the free radical theory of aging as early as 1956 – and it has shaped the cosmetics industry, the dietary supplement industry, and large parts of biogerontology for decades. But the science of 2026 is more complex, precise, and in some respects more surprising than Harman's original hypothesis. Reactive oxygen species are not just damaging molecules; they are also signaling molecules, regulators of cell function, and, in controlled concentrations, necessary for the survival of skin cells. What makes oxidative stress a threat is not the mere presence of ROS, but the imbalance between their production and the skin's capacity to neutralize them.
This article summarizes the current state of research on oxidative stress and cutaneous aging – from the molecular origins of reactive oxygen species and the endogenous antioxidant enzyme system to the most thoroughly studied exogenous antioxidants and the newer concept of inflammaging as a central driver of aging.
(Rittié & Fisher, 2002, Nat Rev Mol Cell Biol)
(Shindo et al., 1994, J Invest Dermatol)
(Pinnell, 2003, J Am Acad Dermatol)
How Reactive Oxygen Species (ROS) are Formed in the Skin
Reactive oxygen species – or ROS – are highly reactive chemical molecules that carry one or more unpaired electrons or are formed by partial reduction of molecular oxygen. The most relevant ROS in the skin include the superoxide anion radical (O₂•⁻), hydrogen peroxide (H₂O₂), the hydroxyl radical (•OH), and singlet oxygen (¹O₂). Each of these molecules has its own half-life, reactivity, and damage potential – and each requires different enzymatic countermeasures.
The formation of ROS in the skin essentially follows two sources: endogenous metabolic processes and exogenous environmental influences. Endogenously, mitochondria are the largest source of ROS: in the course of oxidative phosphorylation, through which cells produce ATP, an estimated 0.2 to 2 percent of the processed oxygen escapes as superoxide radicals. In addition, NADPH oxidases (NOX enzymes), xanthine oxidase, and microsomal cytochrome P450 enzymes continuously generate ROS as by-products of their normal function. In keratinocytes and fibroblasts, these sources are well documented.
Exogenously, ultraviolet radiation dominates as an ROS inducer. UVB (280–315 nm) is directly absorbed by DNA chromophores, generating singlet oxygen and superoxide radicals. UVA (315–400 nm) penetrates deeper into the dermis and also generates substantial amounts of ROS via photosensitizing chromophores such as porphyrins, melanin, and NADH – with a damage pattern that extends more to mitochondrial DNA and dermal connective tissue. In addition, ozone, nitrogen dioxide, and particulate matter from urban air pollution oxidize lipids on the skin surface to reactive aldehydes and can compromise barrier function, leading to a systemic amplification of oxidative stress.
The balance is crucial. Low, controlled concentrations of ROS are physiologically indispensable: they regulate cell growth, differentiation, wound healing, and immune response via signaling pathways such as NF-κB, Nrf2, and MAPK. Only when the production rate exceeds the neutralizing capacity of the antioxidant system – a state that research defines as oxidative stress – do ROS cause cumulative damage to lipids, proteins, and nucleic acids. In the skin, this manifests long-term as collagen degradation, loss of elasticity, hyperpigmentation, and barrier weakness.
ROS are not pure enemies of the skin. In physiological concentrations, they activate the transcription factor Nrf2, which in turn upregulates antioxidant protective genes – a cellular adaptation mechanism that research calls hormesis. Only chronic excess tipped the balance towards damage.
The Antioxidant Enzyme System: SOD, Catalase, and Glutathione Peroxidase
The skin possesses a sophisticated endogenous antioxidant enzyme system that acts at multiple levels. The main players are superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) – three classes of enzymes that together form a coordinated detoxification cascade for the superoxide radical down to harmless water.
Superoxide Dismutase (SOD) catalyzes the dismutation of superoxide anions to hydrogen peroxide and molecular oxygen. Three isoforms exist in the human body: cytosolic Cu/Zn-SOD (SOD1), mitochondrial Mn-SOD (SOD2), and extracellular EC-SOD (SOD3). For skin biology, EC-SOD is particularly relevant as it is expressed in the dermis and on the keratinocyte surface, thus representing the first line of defense against extracellular oxidative stress. Studies by Shindo et al. (1994) showed a significant decrease in total SOD activity in aged human skin, which correlated with increased lipid peroxidation.
Catalase (CAT) takes over in the second step, disproportionating hydrogen peroxide into water and oxygen. It is predominantly located in peroxisomes and highly expressed in keratinocytes. With increasing age, its activity in the epidermis measurably decreases, which can lead to an accumulation of H₂O₂ – a relatively stable oxidant that penetrates membranes and generates the highly reactive hydroxyl radical in the Fenton mechanism with iron ions.
Glutathione Peroxidase (GPx) complements catalase activity through the selenium-dependent reduction of H₂O₂ and organic hydroperoxides, consuming reduced glutathione (GSH). In the skin, GPx1 and GPx4 are the dominant isoforms; GPx4 plays a special role in protecting membrane phospholipids from peroxidation. The total glutathione content of the skin decreases with age – a finding consistently replicated across several studies and considered a reliable marker for cumulative oxidative stress.
These three main enzymes are complemented by the thioredoxin-peroxiredoxin system, glutaredoxins, and the NADPH-regenerating glutathione reductase. All these systems are metabolically costly – they require cofactors such as selenium, zinc, manganese, copper, and NADPH – which explains why their capacity is the first to decline in cases of systemic nutrient deficiency or chronic illness.
The age-related decrease in antioxidant enzyme activity in the skin is not a monocausal process. Genetic polymorphisms in SOD2 and GPx1, epigenetic changes at enzyme promoters, and reduced Nrf2 activation with increasing age act together. Topical strategies cannot directly replace endogenous enzymes, but can provide support by supplying relevant cofactors and activating protective genes via Nrf2 – as current work on niacinamide and resveratrol shows.
Exogenous Antioxidants: Vitamin C, E, Resveratrol, Astaxanthin, and More
In parallel with the endogenous protective system, the skin receives exogenous antioxidants through diet and topical application. Research over the past two decades has painted a differentiated picture here: not every antioxidant works in every location, at every concentration, and through the same mechanism.
Vitamin C (L-Ascorbic Acid)
Vitamin C is the most intensively studied topical antioxidant in dermatology. As a water-soluble molecule, it acts in the aqueous compartments of cells and the interstitium, where it directly scavenges superoxide radicals, hydroxyl radicals, and singlet oxygen. Furthermore, it regenerates oxidized vitamin E (tocopheroxyl radical) back into its active form – a synergism central to the skin's antioxidant protection strategy. A third mechanism, well documented by Pinnell et al. (2001): Vitamin C stimulates collagen synthesis through the hydroxylation of proline and lysine residues, thus directly counteracting age-related matrix degradation. Topical bioavailability is concentration-dependent and highly formulation-dependent; L-ascorbic acid at a pH below 3.5 and in concentrations of 10–20% shows the most consistent efficacy in clinical studies.
Vitamin E (Tocopherols and Tocotrienols)
Vitamin E – essentially α-tocopherol – is the primary lipophilic antioxidant in cell membranes and lipoproteins. It interrupts the chain reaction of lipid peroxidation by scavenging the peroxyl radical, thereby becoming a tocopheroxyl radical itself, which can be regenerated by vitamin C. In the skin, α-tocopherol is found in high concentrations in the stratum corneum, where it is transported via sebum. UV exposure rapidly depletes these reserves; studies show that a single UV dose can reduce skin surface tocopherol levels by up to 50%. Tocotrienols – the less studied vitamin E isomers – show stronger neuroprotective and anti-inflammatory effects in newer in vitro studies than α-tocopherol and are considered a promising area of research.
Resveratrol
Resveratrol, a stilbenoid from grape seeds, berries, and peanuts, has gained significant scientific attention due to its activation of the enzyme Sirtuin 1 (SIRT1). SIRT1 is an NAD+-dependent deacetylase that regulates, among other things, the activity of p53, NF-κB, and PGC-1α, thereby influencing senescence, inflammatory response, and mitochondrial biogenesis. Topically applied resveratrol shows effects on UV-induced erythema reaction and markers of matrix metalloproteinase activity (MMP-1, MMP-3) in controlled studies. A formulation problem: Resveratrol is photochemically unstable and oxidizes rapidly; modern encapsulation technologies significantly improve its stability and dermal penetration.
Astaxanthin
Astaxanthin is a xanthophyll carotenoid from the microalgae Haematococcus pluvialis and is currently considered the carotenoid with the strongest antioxidant capacity, measured by the ORAC method (Oxygen Radical Absorbance Capacity). Unlike other carotenoids, astaxanthin can be anchored in both the aqueous and lipophilic phases of the membrane, protecting both sides of the lipid bilayer simultaneously – a structural property that significantly increases its effectiveness compared to β-carotene and lutein. Clinical studies with oral supplementation show an improvement in skin elasticity, moisture content, and wrinkle depth after 6–8 weeks. Positive data also exist for topical application, although the study situation here is still more heterogeneous.
Niacinamide (Nicotinamide, Vitamin B3)
Niacinamide plays a special role in the antioxidant context: it does not primarily act as a direct antioxidant, but as a precursor to NAD+, the central cofactor of cellular redox reactions and at the same time a substrate for sirtuins and PARP enzymes involved in DNA repair and senescence regulation. Topically applied niacinamide in concentrations of 4–5% showed reductions in hyperpigmentation, wrinkle formation, and transepidermal water loss in randomized controlled studies. Its anti-inflammatory properties – via inhibition of CXCL-mediated immune cell recruitment – make it a particularly versatile active ingredient in the context of inflammaging.
Coenzyme Q10 (Ubiquinol/Ubiquinone)
Coenzyme Q10 (CoQ10) is an essential component of the mitochondrial electron transport chain and, in its reduced form (ubiquinol), a potent membrane-bound antioxidant. In human skin, CoQ10 levels decrease with age, particularly pronounced in the epidermis. Topical CoQ10 has been shown to penetrate the epidermis and reduce UV-induced oxidative damage there. Clinical studies showed improvements in crow's feet and skin texture after several weeks of application. The formulation stability of ubiquinol (active form) is challenging; ubiquinone is more stable but must be reduced intracellularly to ubiquinol.
Synergies and Interactions in the Antioxidant Network
One of the most important findings of antioxidant research over the past decade is that isolated antioxidants in higher doses are often less effective – and potentially even counterproductive – than combined approaches in physiological concentrations. The classic example is the vitamin C/E pair: Vitamin E scavenges peroxyl radicals in membranes and is oxidized itself in the process. Vitamin C regenerates it – but only if both molecules are present in close proximity and in sufficient concentration. If vitamin C is absent, the tocopheroxyl radical can itself become a prooxidative agent.
Another synergistic network connects glutathione, thioredoxin, and vitamin C: dehydroascorbic acid (oxidized vitamin C) can be reduced back to L-ascorbic acid by glutathione and thioredoxin reductase. This recycling loop explains why the total glutathione content of the skin serves as a systemic marker of antioxidant capacity, even though glutathione itself shows little significant topical penetration.
Resveratrol and niacinamide address a meta-level mechanism via the sirtuin/NAD+ axis: they not only improve immediate ROS neutralization but also long-term enhance the cellular capacity for self-repair and the synthesis of endogenous antioxidant systems. Current formulation concepts combining resveratrol and niacinamide show additive effects on skin tone and elasticity in early clinical data that go beyond the sum of the individual substances.
"Antioxidants are not a single shield, but a network – and like any network, it is only as strong as its weakest link."
Astaxanthin complements this network with its unique membrane-stabilizing geometry and its capacity to physically quench singlet oxygen – a mechanism not achieved by vitamin C or vitamin E with comparable efficiency. The combination of lipophilic astaxanthin, amphipathic vitamin E, and water-soluble vitamin C can thus achieve broader coverage of various ROS species and cellular compartments than any single substance alone.
Inflammaging: Chronic Inflammation as a Major Driver of Skin Aging
The term inflammaging – coined by Claudio Franceschi in 2000 – describes the phenomenon of chronic low-grade systemic inflammation that establishes itself with increasing age and is centrally involved in biological aging processes. In the skin, inflammaging manifests as persistent activation of NF-κB, increased expression of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), and activation of matrix metalloproteinases, particularly MMP-1 (collagenase) and MMP-3 (stromelysins), which drive collagen and elastin degradation in the dermis.
Oxidative stress and inflammaging are not parallel but bidirectionally linked processes: ROS activate NF-κB; NF-κB induces pro-inflammatory enzymes like COX-2 and iNOS, which in turn generate further ROS and reactive nitrogen species (RNS). This positive feedback system is one of the core reasons for the persistence of the aging phenotype in the skin and explains why isolated antioxidant measures alone cannot permanently interrupt the aging spiral.
Another key player in the context of inflammaging is cellular senescence. Senescent fibroblasts and keratinocytes lose their proliferative capacity but remain metabolically active and secrete a characteristic cocktail of cytokines, chemokines, and proteases – the so-called Senescence-Associated Secretory Phenotype (SASP). SASP components amplify local inflammation and induce senescence in neighboring cells (bystander senescence), leading to a progressive spread of the aging phenotype. Oxidative stress is one of the strongest inducers of cellular senescence; conversely, senescent cells themselves produce elevated amounts of ROS.
Recent work shows that the circadian rhythm has a direct influence on inflammaging regulation. The nocturnal peak expression of repair enzymes, the morning upregulation of antioxidant capacity, and the time-of-day-dependent fluctuation of NF-κB activity suggest that the timing of topical application of antioxidant active ingredients can influence their efficacy potential – an aspect that is gaining increasing importance in chrono-cosmetics.
The importance of the gut microbiome for cutaneous inflammaging is another active research area. The gut-skin axis – mediated via short-chain fatty acids, tryptophan metabolites, and immune cell migration – influences systemic inflammatory status and thus indirectly skin function. Studies on pro- and prebiotics show initial indications of a reduction in inflammation-associated skin conditions, although causality and dose-dependency have not yet been conclusively clarified.
Latest research findings and their significance for skin care
The research landscape surrounding oxidative stress and skin aging has evolved in several new directions over the past five years. Three trends deserve special attention.
Nrf2 as a central protective switch. The transcription factor Nrf2 (Nuclear factor erythroid 2-related factor 2) is now considered a central inducer of antioxidant and cytoprotective genes. Under oxidative stress, Nrf2 dissociates from its repressor Keap1, translocates to the cell nucleus, and activates genes coding for glutathione synthase, heme oxygenase-1, thioredoxin reductase, and other protective proteins via Antioxidant Response Elements (ARE). With increasing age, Nrf2 activability in the skin decreases – a finding that explains one mechanism why older skin adapts less well to oxidative stimuli. Substances that activate Nrf2 are therefore a focus of cosmetic research: resveratrol, sulforaphane (from broccoli sprouts), and certain polyphenol mixtures show Nrf2-activating capacity in preclinical studies.
Mitohormesis and mitochondrial quality control. The mitohormesis hypothesis states that mild mitochondrial ROS production activates protective signaling cascades that promote cell longevity. This finding has fundamentally challenged the simple picture – less ROS is always better. For cosmetic practice, this means: Superphysiologically high antioxidant concentrations can theoretically suppress adaptive protective reactions. The dosage and formulation of antioxidants are therefore not trivial and represent one of the most active research fields in cosmeceuticals.
Lipid peroxidation and ferroptosis. A previously little-noticed mechanism is gaining importance: ferroptosis, a regulated form of cell death triggered by uncontrolled lipid peroxidation – particularly oxidized phosphatidylethanolamines. GPx4 is the central antagonist of ferroptotic processes. Disruptions to GPx4 activity in the skin, for example due to selenium deficiency or chronic oxidative stress, can contribute to the persistence of senescent cells and impair barrier regeneration. Initial cosmetic formulation approaches that incorporate selenium peptides or GPx4 cofactors are under development.
Based on the current state of research, several evidence-based priorities can be derived for skin care: The combination of vitamins C and E as a complementary water-soluble-lipophilic pair remains the best-documented topical antioxidant approach. Niacinamide should be considered a basic active ingredient due to its diverse mechanisms of action – NAD+ booster, barrier stabilizer, anti-inflammaging. Astaxanthin and resveratrol can be usefully integrated via complementary mechanisms (singlet oxygen quenching, sirtuin activation). CoQ10 addresses the mitochondrial dimension of oxidative stress and is increasingly being researched in combination with NMN (nicotinamide mononucleotide), as both interact via the NAD+ axis.
As important as the choice of active ingredients is the timing of application. The chronobiology of the skin – with increased antioxidant enzyme activity in the morning and repair processes at night – suggests applying light- and environmentally stable antioxidants in the morning, while regenerative substances such as retinol, niacinamide, and peptides can be optimally utilized in the evening. This corresponds to the principle of Chrono-Barrier Skin Science™ – the rhythmic adaptation of care to the skin's biological clock.
What exactly is the difference between free radicals and oxidative stress?
Free radicals – more precisely: reactive oxygen species (ROS) – are chemically unstable molecules with unpaired electrons. They are constantly formed during cell metabolism and by environmental influences. Oxidative stress describes the state in which the production of these molecules exceeds the neutralizing capacity of the antioxidant system. Low amounts of ROS are physiologically important; only an excess causes damage to cell structures.
Can topical antioxidants be over-dosed?
The question is controversially discussed in research. There are indications – particularly from mitohormesis research – that very high antioxidant concentrations can suppress adaptive protective reactions of the cell. For topical application, formulation aspects such as stability, pH value, and penetration depth also play a role. Clinically established concentrations for vitamin C are 10–20%, for niacinamide 4–5%. Significantly higher dosages rarely offer proportionally more benefit.
What is inflammaging and why is it relevant for the skin?
Inflammaging describes a chronic low-grade systemic inflammation that establishes itself with age. In the skin, it activates enzymes that break down collagen and elastin (matrix metalloproteinases) and promotes cellular senescence. Oxidative stress and inflammaging reinforce each other in a feedback loop. Active ingredients such as niacinamide and resveratrol address both levels simultaneously.
How does the daily rhythm influence the skin's oxidative protection?
The skin has a circadian rhythm that temporally coordinates the activity of antioxidant enzymes, barrier regeneration, and DNA repair capacity. The antioxidant defense is particularly active in the morning – adapted to UV and environmental exposure throughout the day. Repair processes primarily occur at night. Consciously adapting the care strategy to this rhythm – protection in the morning, regeneration in the evening – can support the effectiveness of the care.
- Harman D. (1956). Aging: A theory based on free radical and radiation chemistry. Journal of Gerontology, 11(3), 298–300.
- Rittié L., Fisher G.J. (2002). UV-light-induced signal cascades and skin aging. Ageing Research Reviews, 1(4), 705–772.
- Shindo Y., Witt E., Han D., Packer L. (1994). Dose-response effects of acute ultraviolet irradiation on antioxidants and molecular markers of oxidation in murine epidermis and dermis. Journal of Investigative Dermatology, 102(4), 470–475.
- Pinnell S.R. (2003). Cutaneous photodamage, oxidative stress, and topical antioxidant protection. Journal of the American Academy of Dermatology, 48(1), 1–19.
- Pinnell S.R., Yang H.S., Omar M. et al. (2001). Topical L-ascorbic acid: Percutaneous absorption studies. Dermatologic Surgery, 27(2), 137–142.
- Franceschi C., Bonafè M., Valensin S. et al. (2000). Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences, 908, 244–254.
- Itoh K., Chiba T., Takahashi S. et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications, 236(2), 313–322.
- Yakes F.M., Van Houten B. (1997). Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. PNAS, 94(2), 514–519.
- Ristow M., Schmeisser S. (2011). Extending life span by increasing oxidative stress. Free Radical Biology and Medicine, 51(2), 327–336.
- Lykkesfeldt J., Michels A.J., Frei B. (2014). Vitamin C. Advances in Nutrition, 5(1), 16–18.
- Kohen R., Nyska A. (2002). Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic Pathology, 30(6), 620–650.
- Kensler T.W., Wakabayashi N., Biswal S. (2007). Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology, 47, 89–116.
- Hayashi N., Watanabe Y., Nakanishi Y. et al. (2020). Astaxanthin and skin health. Nutrients, 12(2), 435.
- Draelos Z.D. (2010). Niacinamide in skin care. Journal of Cosmetic Dermatology, 9(4), 282–289.
- Sinclair D.A., Guarente L. (2014). Small-molecule allosteric activators of sirtuins. Annual Review of Pharmacology and Toxicology, 54, 363–380.